Press Releases IP Group Plc

Equities

IPO

GB00B128J450

Investment Management & Fund Operators

Market Closed - London S.E. Other stock markets 11:35:04 2024-12-02 am EST			5-day change	1st Jan Change
45.60 ^GBX	+3.64%		+5.80%	-21.51%

Nov. 18	IP Group investee AMSL Aero completes first free flight of Vertiia	AN
Oct. 30	DiffBlue Limited announced that it has received $6.3 million in funding from IP Group Plc, University of Oxford, Parkwalk Advisors Ltd, AlbionVC, Oxford Investment Consultants LLP, and other investors	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

IP : Oxford Nanopore and UK Biobank to create world's largest epigenetic dataset targeting the causes of cancer, dementia, complex disease	Nov. 27	PU
IP : C-Capture’s technology in biofuels trial to achieve net zero	Nov. 20	PU
IP : Microbiotica Announces First Patient Dosed in its Phase 1b Trial (COMPOSER-1) of MB310, a Precision Microbiome Medicine, in Ulcerative Colitis Patients	Nov. 13	PU
IP : STORM Therapeutics Presents New Clinical Data on its First in Class METTL3 Inhibitor STC 15 at SITC 2024	Nov. 12	PU
IP : Oxford Nanopore announces senior leadership changes	Nov. 12	PU
IP : New strategic partnership between UK Biobank, Genomics England, NHS England and Oxford Nanopore	Nov. 05	PU
IP : Ieso Digital Health Appoints Kent Tangen as New CEO to Drive Digital Mental Health Innovation in the United States	Nov. 04	PU
IP : Diffblue Secures $6.3 Million in New Funding Amidst 3x Growth Period	Oct. 30	PU
IP : Oxa Unveils Autonomous Ford E-Transit Van and Minibus	Oct. 29	PU
IP : Dr. Falk Pharma acquires Kynos Therapeutics, adding acute pancreatitis as a therapeutic focus and further strengthening its development portfolio	Oct. 29	PU
IP : Alimetry raises US$18m for next phase of growth	Oct. 24	PU
IP : Quantum Dice and SCI Semiconductor announce partnership to bring quantum-backed cryptography to advanced security systems	Oct. 22	PU
IP : STORM Therapeutics to Present Phase 1 Data on its First in Class Lead Product STC 15 at EORTC NCI AACR Symposium	Oct. 09	PU
IP : AMSL Aero Signs International Partnership with Philippines Bases Conversion and Development Authority	Oct. 03	PU
IP : Intelligent Ultrasound Group plc - Completion of sale of Clinical AI Business	Oct. 01	PU
IP : Genomics Announces David Thornton as President	Oct. 01	PU
IP : Life Flight Becomes AMSL Aero's First New Zealand Development Partner for "Vertiia" Zero Emissions Aircraft to Support Future Australasian Aeromedical Operations	Sep. 24	PU
IP : Alesi Surgical secures FDA clearance for its revolutionary open surgery device	Sep. 19	PU
IP : StreetDrone Now Part of Oxa, Bolstering Oxa’s Position in Industrial Logistics	Sep. 18	PU
IP : Moa and Biomar announce bio-herbicide collaboration	Sep. 16	PU
IP : Tissue Regenix Group plc - Interim results for the six months ended 30 June 2024	Sep. 10	PU
IP : Oxford Nanopore seeks discovery in connection with anticipated breach of contract action	Sep. 10	PU
IP : Microbiotica’s Microbiome Medicines in Melanoma and Ulcerative Colitis Gain Regulatory Approvals in EU and UK for Phase 1b Studies	Aug. 27	PU
IP : Oxa Third Commercial Deployment of Oxa's Self driving Software in the United States, in Collaboration With Beep	Aug. 22	PU
IP : Moa announces international field trial success at the ACS autumn conference in Denver	Aug. 20	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases IP Group Plc

Equities

IPO

GB00B128J450

Investment Management & Fund Operators

Press Releases

Filters